ProteinQure Inc.
25.3.2024 05:03:30 CET | ACCESS Newswire | Press release
TORONTO, ON / ACCESSWIRE / March 25, 2024 / ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in the fight against triple-negative breast cancer (TNBC). The novel Peptide Drug Conjugate (PDC) designed by ProteinQure demonstrated exceptional efficacy in a comprehensive suite of Patient-Derived Xenograft (PDX) models. The experiments were conducted in the lab of Dr. David Cescon at the Princess Margaret Cancer Centre/University Health Network, one of the world's top five cancer research centres.
Developed through ProteinQure's cutting-edge computational platform, the innovative SORT1 targeting PDC is a novel peptide attached to a highly potent chemotherapeutic agent. The drug candidate was tested across a broad range of breast cancer models. The results demonstrated remarkable antitumor efficacy, including cancers resistant to standard chemotherapies and antibody-drug conjugates.
"Working with the David Cescon Lab at UHN has been instrumental in validating our novel PDC's efficacy against one of the most challenging forms of breast cancer. Based on these results, we are moving our lead program forward into IND-Enabling studies and our first clinical trial," said Lucas Siow, CEO of ProteinQure. "These findings not only highlight the power of our computational drug design platform but also represent significant validation in our quest to develop tissue-specific peptides for targeted drug delivery."
ProteinQure's collaborators will present the data at the upcoming American Association for Cancer Research (AACR) conference in San Diego. The AACR conference, renowned for showcasing the latest innovations in cancer research, provides the perfect stage to share these findings with the global cancer research community.
"We are excited to present this data at AACR and help develop new therapeutic options for breast cancer, especially with promising Canadian startups," stated Dr. David Cescon, head of the lab at UHN. "The success of this unique PDC in diverse PDX models is a testament to the potential of combining advanced computational techniques, precision oncology, and our labs' robust preclinical platform".
Funding for parts of this work included contributions from IRAP-Canada and the INOVAIT program based out of Sunnybrook Hospital.
Poster Presentation Details:
Title: In-vivo efficacy of a novel peptide-conjugated drug in patient-derived xenograft models of breast cancer
Session Title: New Targets
Date and Time: Tuesday, April 9, at 1:30 p.m. PT/4:30 p.m. ET
Abstract Number: 5911
Speaker: Mitchell Elliott, UHN Princess Margaret Cancer Centre
About ProteinQure
ProteinQure is a pioneering startup specializing in the computational design of peptide drugs utilizing state-of-the-art artificial intelligence and molecular simulation technologies. With a focus on precision medicine, ProteinQure is dedicated to transforming the landscape of drug development and ushering in a new era of targeted effective treatments.
About the David Cescon Lab at UHN
The David Cescon Lab at the University Health Network is a leader in breast cancer research, focusing on the mechanisms of cancer progression and resistance to therapy. Through cutting-edge pre-clinical and clinical research and collaborations, the lab develops novel therapeutic strategies aimed at improving outcomes for cancer patients worldwide.
For further information, please contact:
Lucas Siow - CEO of ProteinQure - press@proteinqure.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
SOURCE: ProteinQure Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG7.4.2026 15:00:00 CEST | Press release
CALGARY, AB / ACCESS Newswire / April 7, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions provider operating across compliance and voluntary carbon markets, today announced a strategic collaboration with carbon-connect AG ("carbon-connect"), a Switzerland-based greenhouse gas (GHG) accounting and sustainability advisory firm. The collaboration marks a continued expansion of Karbon-X's enterprise climate platform, strengthening its carbon measurement, decarbonization advisory, and ongoing monitoring capabilities for corporate and regulated clients. Karbon-X will lead commercial engagement and client integration, incorporating carbon-connect's technical expertise into its end-to-end climate solutions framework. The enhanced service offering includes: Full Scope 1,2, and 3 emissions accounting Emissions abatement planning and implementation Country-specific compliance, ESG, and sustainability reporting Product carbon quantificatio
U.S. Polo Assn. and ESPN Champion the Iconic USPA Gold Cup at the USPA National Polo Center, Hosted by Legendary Commentator Chris Fowler7.4.2026 13:00:00 CEST | Press release
USPA Gold Cup Finals to Air on ESPN and Global Polo Platforms WEST PALM BEACH, FL / ACCESS Newswire / April 7, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the USPA Gold Cup® at the USPA National Polo Center (NPC) in Wellington, Florida on April 5, 2026, Easter Sunday in front of a record crowd at the U.S. Polo Assn. Stadium Field.1. 2026 USPA Gold Cup Winners, Team Pilot (#1 Curtis Pilot - 0, #2 Mackenzie Weisz - 6, #3 Lorenzo Chavanne - 7, #4 Camilo ‘Jeta' Castagnola - 10) on stage with iconic trophy at the USPA National Polo Center - Wellington, Florida 2. Cousins, but rivals on the field - Pilot's Camilo ‘Jeta' Castagnola and La Dolfina Scone's Poroto Cambiaso battle for the ball at the 2026 USPA Gold Cup Final Photo Credit: Augustina Fonda As the second most prestigious tournament in the United States and a critical leg of the Gauntlet of Polo®, the USPA Gold Cup brings together the sport's top players and elite
Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush × Zurich 20266.4.2026 15:15:00 CEST | Press release
Building Global Momentum Ahead of Upcoming XRP Tokyo Event PHILADELPHIA, PA / ACCESS Newswire / April 6, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in AI-driven data valuation, monetization, credentialing, digital engagement, and real-world asset (RWA) tokenization technologies, today announced that CEO Nathaniel T. Bradley will deliver high-impact keynote presentations at two premier European financial innovation events this spring. On April 22, 2026, Bradley will headline CONV3RGENCE London & The Digital Commonwealth Awards 2026 at the historic Mansion House in London as Flagship Partner. One month later, on May 21, 2026, he will take center stage as Main Strategic Partner at AssetRush × Zurich 2026, GenTwo's flagship "festival of financial innovation" at Kaufleuten Zurich, delivering the opening speech and a major talk on the future of tokenized assets. These back-to-back European keynotes build on Bradley's upcoming presentation at XRP Tokyo
Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 20262.4.2026 18:32:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / April 2, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that CEO Nathaniel (Nate) T. Bradley will present and exhibit the Company's DataValue®, DataScore®, Data Vault Bank® AI Agent, and patented Information Data Exchange® technologies at XRP Tokyo 2026 on April 7, 2026, at Happo-en in Tokyo, Japan. Bradley's presentation, "Data-Driven RWA Tokenization: Unlocking Japan's Trillion-Yen Opportunity on the XRP Ledger," will demonstrate how Datavault AI's platforms support secure, AI-powered tokenization of real estate, commodities, and other high-value assets in Japan's regulation-friendly market. Japan has emerged as Asia's leading real-world asset tokenization market, with institutional platforms such as Progmat (MUFG-backed) managing approximately ¥440 billion (~$2.8 billion USD) in token
Valsoft Corporation Strengthens Its Retail Software Portfolio with the Acquisition of NedFox2.4.2026 15:00:00 CEST | Press release
MONTRÉAL, QC / ACCESS Newswire / April 2, 2026 / Valsoft Corporation Inc. ("Valsoft"), a Montreal-based company specializing in the acquisition and development of vertical market software businesses, is pleased to announce the acquisition of NedFox, the Netherlands-based software producer of RetailVista, a comprehensive Retail ERP platform designed to support modern retail operations. Headquartered in the Netherlands, NedFox develops and markets RetailVista, an integrated cloud-based Retail ERP solution that enables retailers to manage point-of-sale, inventory, purchasing, financial administration, and reporting within a unified environment. With a strong focus on continuous innovation and customer-driven development, NedFox has built a reputation for delivering reliable, scalable software tailored to the evolving needs of retail businesses. "NedFox has built a robust and highly regarded Retail ERP platform with RetailVista, supported by a passionate team and a strong customer focus,"
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom